The Heart Drug Pelacarsen Fails, Shocking Novartis and Cardiologists
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Search fresh public links, source activity, and ready-to-use post angles for New England Journal Of Medicine.
Fresh curated links around New England Journal of Medicine are collected here so marketers can spot useful updates and turn timely ideas into posts faster.
Recent items include:
Recent curated links from global sources. Generate one free draft from any story, then use SocialBu to schedule and refine your content calendar.
Doctors were hopeful the drug, which was being tested in a large clinical trial by Novartis, was going to be a powerful new tool to fight heart disease.
Results published in NEJM raised questions about the benefits “silencer” medications provide on top of standard therapies for TTR cardiomyopathy and amplified investor pressure on...
A small gene-editing study significantly reduced LDL cholesterol levels, and the results have stuck a year later.
Honors pioneering work at Presbyterian Hospital in Pittsburgh led by members of NGD Infection Prevention's Scientific Advisory Board
Journal Feed covers D10 vs D50 for hypoglycemia, virus detection in infants and IBI, and TEE guided chest compressions. The post Journal Feed Weekly Wrap-Up appeared first on emDoc...
Journal Feed covers duration of hypothermia post ROSC, ramping for intubation, and discharging low-risk PE patients. The post Journal Feed Weekly Wrap-Up appeared first on emDocs.
It seems like every few years, someone tests whether further risk stratification in patients following a negative workup for acute coronary syndrome (ACS) provides a clinically mea...
The first-of-its-kind drug offers a reprieve for people who live with the debilitating sleep disorder.
Modern scientific medicine has given humanity extraordinary tools. Antibiotics transformed once-lethal infections into treatable illnesses. Cardiovascular medications prevent strok...
A New York transplant surgeon’s experience waiting for a heart transplant laid bare the challenges of a system he had spent decades trying to fix.
Cardiologists are struggling to figure out why a drug that should have prevented heart attacks didn’t work at all.
Just when I thought I was out, they pull me back in. -Michael Corleone A new meta-analysis by Liu et al. was just published in Frontiers in Medicine, comparing balanced crystalloid...
You are the science news desk of a major English-language science magazine. Complete the task immediately. Never ask the reader what to do, never offer editing options, and never r...
The following is the result of joint work with Jaroslav Janosek, Tadeas Frycak, and Robert Straka. Introduction Since the registration trials of the Covid-19 vaccines, there have b...
I have spent decades in health care. I know how much physicians rely on clinical judgment, pattern recognition, and experience. Those skills matter, and they also carry a risk: The...
SCCM recently published updated guidelines on neuromuscular blockade in ARDS. The authors present five recommendations, the first being the most potentially influential on practice...
The new disclosure suggested Rasonque might not be as broadly effective as previously thought. Elsewhere, Ultragenyx got a much-needed cash infusion and TCGX started a China-focuse...
Use SocialBu to discover ideas, generate post drafts, and schedule them across your social channels.